Cargando…
Non-Invasive Indirect Markers of Liver Fibrosis after Interferon-Free Treatment for Hepatitis C
The effectiveness of interferon-free therapy during the course of HCV infection has already been confirmed. Liver fibrosis can be assessed in several ways, from biopsies to imaging tests. The present study evaluates the usefulness of non-invasive indirect biomarkers of liver fibrosis (APRI, GAPRI, F...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432198/ https://www.ncbi.nlm.nih.gov/pubmed/34501398 http://dx.doi.org/10.3390/jcm10173951 |
_version_ | 1783751108421746688 |
---|---|
author | Przekop, Dagmara Klapaczynski, Jakub Grytczuk, Agnieszka Gruszewska, Ewa Gietka, Andrzej Panasiuk, Anatol Golaszewski, Slawomir Cylwik, Bogdan Chrostek, Lech |
author_facet | Przekop, Dagmara Klapaczynski, Jakub Grytczuk, Agnieszka Gruszewska, Ewa Gietka, Andrzej Panasiuk, Anatol Golaszewski, Slawomir Cylwik, Bogdan Chrostek, Lech |
author_sort | Przekop, Dagmara |
collection | PubMed |
description | The effectiveness of interferon-free therapy during the course of HCV infection has already been confirmed. Liver fibrosis can be assessed in several ways, from biopsies to imaging tests. The present study evaluates the usefulness of non-invasive indirect biomarkers of liver fibrosis (APRI, GAPRI, FORNS, FIB-4, the AP index and HUI score) as markers of the effective treatment of HCV with the 3D regimen. Blood samples were collected from 70 patients suffering from chronic hepatitis C. Patients received the 3D AbbVie regimen for hepatitis C. All patients had HCV genotype 1b. The APRI, GAPRI, FIB-4, FORNS, HUI and AP index (age–platelet score) values were calculated with their respective algorithms. The stage of fibrosis was evaluated on the basis of a liver biopsy and confirmed by FibroScan-based transient elastography. An undetectable level of HCV RNA after 12 weeks of treatment with the 3D regimen indicates 100% eradication of hepatitis C virus. After the treatment, non-invasive indirect markers of liver fibrosis achieved levels below the limit for significant fibrosis, Thus, non-invasive indirect biomarkers of hepatic fibrosis failed to detect the presence of significant fibrosis, which was proved in histopathological examination. However, the eradication of hepatitis C virus by means of the 3D regimen treatment does not mean that patients were completely cured. |
format | Online Article Text |
id | pubmed-8432198 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84321982021-09-11 Non-Invasive Indirect Markers of Liver Fibrosis after Interferon-Free Treatment for Hepatitis C Przekop, Dagmara Klapaczynski, Jakub Grytczuk, Agnieszka Gruszewska, Ewa Gietka, Andrzej Panasiuk, Anatol Golaszewski, Slawomir Cylwik, Bogdan Chrostek, Lech J Clin Med Article The effectiveness of interferon-free therapy during the course of HCV infection has already been confirmed. Liver fibrosis can be assessed in several ways, from biopsies to imaging tests. The present study evaluates the usefulness of non-invasive indirect biomarkers of liver fibrosis (APRI, GAPRI, FORNS, FIB-4, the AP index and HUI score) as markers of the effective treatment of HCV with the 3D regimen. Blood samples were collected from 70 patients suffering from chronic hepatitis C. Patients received the 3D AbbVie regimen for hepatitis C. All patients had HCV genotype 1b. The APRI, GAPRI, FIB-4, FORNS, HUI and AP index (age–platelet score) values were calculated with their respective algorithms. The stage of fibrosis was evaluated on the basis of a liver biopsy and confirmed by FibroScan-based transient elastography. An undetectable level of HCV RNA after 12 weeks of treatment with the 3D regimen indicates 100% eradication of hepatitis C virus. After the treatment, non-invasive indirect markers of liver fibrosis achieved levels below the limit for significant fibrosis, Thus, non-invasive indirect biomarkers of hepatic fibrosis failed to detect the presence of significant fibrosis, which was proved in histopathological examination. However, the eradication of hepatitis C virus by means of the 3D regimen treatment does not mean that patients were completely cured. MDPI 2021-08-31 /pmc/articles/PMC8432198/ /pubmed/34501398 http://dx.doi.org/10.3390/jcm10173951 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Przekop, Dagmara Klapaczynski, Jakub Grytczuk, Agnieszka Gruszewska, Ewa Gietka, Andrzej Panasiuk, Anatol Golaszewski, Slawomir Cylwik, Bogdan Chrostek, Lech Non-Invasive Indirect Markers of Liver Fibrosis after Interferon-Free Treatment for Hepatitis C |
title | Non-Invasive Indirect Markers of Liver Fibrosis after Interferon-Free Treatment for Hepatitis C |
title_full | Non-Invasive Indirect Markers of Liver Fibrosis after Interferon-Free Treatment for Hepatitis C |
title_fullStr | Non-Invasive Indirect Markers of Liver Fibrosis after Interferon-Free Treatment for Hepatitis C |
title_full_unstemmed | Non-Invasive Indirect Markers of Liver Fibrosis after Interferon-Free Treatment for Hepatitis C |
title_short | Non-Invasive Indirect Markers of Liver Fibrosis after Interferon-Free Treatment for Hepatitis C |
title_sort | non-invasive indirect markers of liver fibrosis after interferon-free treatment for hepatitis c |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432198/ https://www.ncbi.nlm.nih.gov/pubmed/34501398 http://dx.doi.org/10.3390/jcm10173951 |
work_keys_str_mv | AT przekopdagmara noninvasiveindirectmarkersofliverfibrosisafterinterferonfreetreatmentforhepatitisc AT klapaczynskijakub noninvasiveindirectmarkersofliverfibrosisafterinterferonfreetreatmentforhepatitisc AT grytczukagnieszka noninvasiveindirectmarkersofliverfibrosisafterinterferonfreetreatmentforhepatitisc AT gruszewskaewa noninvasiveindirectmarkersofliverfibrosisafterinterferonfreetreatmentforhepatitisc AT gietkaandrzej noninvasiveindirectmarkersofliverfibrosisafterinterferonfreetreatmentforhepatitisc AT panasiukanatol noninvasiveindirectmarkersofliverfibrosisafterinterferonfreetreatmentforhepatitisc AT golaszewskislawomir noninvasiveindirectmarkersofliverfibrosisafterinterferonfreetreatmentforhepatitisc AT cylwikbogdan noninvasiveindirectmarkersofliverfibrosisafterinterferonfreetreatmentforhepatitisc AT chrosteklech noninvasiveindirectmarkersofliverfibrosisafterinterferonfreetreatmentforhepatitisc |